BRITNI TURANO: Open Payments
NPI 1073286019 · RIVERSIDE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$576 in 22 payments from 10 companies in 2025. Trend: 2023 $2,027 · 2024 $545 · 2025 $576
Food & beverage: $576
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 6 | $239 |
| ABBVIE INC. | 4 | $84 |
| Lundbeck LLC | 2 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Alkermes, Inc. | 2 | $40 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
Products named: FANAPT, REXULTI, VRAYLAR, Auvelity, CAPLYTA, LYBALVI, ARISTADA, TRINTELLIX.
Industry payments across RI — which companies pay providers there.
